Logo image of AMK

AssetMark Financial Holdings Inc (AMK) Stock Fundamental Analysis

NYSE:AMK - New York Stock Exchange, Inc. - US04546L1061 - Common Stock - Currency: USD

35.24  -0.02 (-0.06%)

After market: 35.25 +0.01 (+0.03%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to AMK. AMK was compared to 231 industry peers in the Capital Markets industry. AMK has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. AMK has a correct valuation and a medium growth rate. This makes AMK very considerable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year AMK was profitable.
In the past year AMK had a positive cash flow from operations.
In multiple years AMK reported negative net income over the last 5 years.
Each year in the past 5 years AMK had a positive operating cash flow.
AMK Yearly Net Income VS EBIT VS OCF VS FCFAMK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

1.2 Ratios

The Return On Assets of AMK (8.86%) is better than 85.65% of its industry peers.
AMK has a Return On Equity (10.65%) which is in line with its industry peers.
With an excellent Return On Invested Capital value of 10.75%, AMK belongs to the best of the industry, outperforming 84.72% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AMK is in line with the industry average of 7.13%.
The last Return On Invested Capital (10.75%) for AMK is above the 3 year average (6.53%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.86%
ROE 10.65%
ROIC 10.75%
ROA(3y)5.44%
ROA(5y)3.13%
ROE(3y)7.14%
ROE(5y)4.1%
ROIC(3y)6.53%
ROIC(5y)4.35%
AMK Yearly ROA, ROE, ROICAMK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 2 4 6 8 10

1.3 Margins

AMK's Profit Margin of 19.43% is in line compared to the rest of the industry. AMK outperforms 56.02% of its industry peers.
AMK's Profit Margin has improved in the last couple of years.
AMK's Operating Margin of 30.00% is in line compared to the rest of the industry. AMK outperforms 52.31% of its industry peers.
In the last couple of years the Operating Margin of AMK has grown nicely.
AMK has a better Gross Margin (77.45%) than 80.09% of its industry peers.
In the last couple of years the Gross Margin of AMK has grown nicely.
Industry RankSector Rank
OM 30%
PM (TTM) 19.43%
GM 77.45%
OM growth 3Y173.66%
OM growth 5Y12.1%
PM growth 3YN/A
PM growth 5Y11.06%
GM growth 3Y3.85%
GM growth 5Y2.66%
AMK Yearly Profit, Operating, Gross MarginsAMK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, AMK has more shares outstanding
Compared to 5 years ago, AMK has more shares outstanding
Compared to 1 year ago, AMK has an improved debt to assets ratio.
AMK Yearly Shares OutstandingAMK Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
AMK Yearly Total Debt VS Total AssetsAMK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 7.20 indicates that AMK is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 7.20, AMK belongs to the best of the industry, outperforming 91.20% of the companies in the same industry.
AMK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.2
ROIC/WACCN/A
WACCN/A
AMK Yearly LT Debt VS Equity VS FCFAMK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 3.27 indicates that AMK has no problem at all paying its short term obligations.
AMK has a better Current ratio (3.27) than 81.94% of its industry peers.
A Quick Ratio of 3.27 indicates that AMK has no problem at all paying its short term obligations.
AMK has a Quick ratio of 3.27. This is amongst the best in the industry. AMK outperforms 81.94% of its industry peers.
Industry RankSector Rank
Current Ratio 3.27
Quick Ratio 3.27
AMK Yearly Current Assets VS Current LiabilitesAMK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.89% over the past year.
The Earnings Per Share has been growing by 23.75% on average over the past years. This is a very strong growth
AMK shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.67%.
Measured over the past years, AMK shows a quite strong growth in Revenue. The Revenue has been growing by 14.27% on average per year.
EPS 1Y (TTM)22.89%
EPS 3Y31.37%
EPS 5Y23.75%
EPS Q2Q%20%
Revenue 1Y (TTM)8.67%
Revenue growth 3Y17.92%
Revenue growth 5Y14.27%
Sales Q2Q%4.11%

3.2 Future

The Earnings Per Share is expected to grow by 7.93% on average over the next years.
Based on estimates for the next years, AMK will show a small growth in Revenue. The Revenue will grow by 4.07% on average per year.
EPS Next Y16.44%
EPS Next 2Y10.33%
EPS Next 3Y6.26%
EPS Next 5Y7.93%
Revenue Next Year-6.11%
Revenue Next 2Y-1.18%
Revenue Next 3Y0.72%
Revenue Next 5Y4.07%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AMK Yearly Revenue VS EstimatesAMK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
AMK Yearly EPS VS EstimatesAMK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 14.27 indicates a correct valuation of AMK.
Compared to the rest of the industry, the Price/Earnings ratio of AMK is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 24.21. AMK is valued slightly cheaper when compared to this.
AMK is valuated correctly with a Price/Forward Earnings ratio of 12.64.
AMK's Price/Forward Earnings ratio is in line with the industry average.
AMK's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 20.44.
Industry RankSector Rank
PE 14.27
Fwd PE 12.64
AMK Price Earnings VS Forward Price EarningsAMK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AMK is valued cheaply inside the industry as 87.04% of the companies are valued more expensively.
AMK's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 21.82
EV/EBITDA 9.25
AMK Per share dataAMK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of AMK may justify a higher PE ratio.
PEG (NY)0.87
PEG (5Y)0.6
EPS Next 2Y10.33%
EPS Next 3Y6.26%

0

5. Dividend

5.1 Amount

AMK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AssetMark Financial Holdings Inc

NYSE:AMK (9/4/2024, 8:18:01 PM)

After market: 35.25 +0.01 (+0.03%)

35.24

-0.02 (-0.06%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)07-18 2024-07-18/amc
Earnings (Next)11-04 2024-11-04/amc
Inst Owners0.72%
Inst Owner Change-36.33%
Ins Owners3.83%
Ins Owner Change0%
Market Cap2.64B
Analysts72.5
Price Target37.13 (5.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.44%
Min EPS beat(2)-1.49%
Max EPS beat(2)-1.4%
EPS beat(4)2
Avg EPS beat(4)1.18%
Min EPS beat(4)-1.49%
Max EPS beat(4)5.84%
EPS beat(8)4
Avg EPS beat(8)1.65%
EPS beat(12)7
Avg EPS beat(12)2.09%
EPS beat(16)10
Avg EPS beat(16)2.94%
Revenue beat(2)0
Avg Revenue beat(2)-2.14%
Min Revenue beat(2)-2.48%
Max Revenue beat(2)-1.79%
Revenue beat(4)1
Avg Revenue beat(4)3.36%
Min Revenue beat(4)-16.64%
Max Revenue beat(4)34.37%
Revenue beat(8)4
Avg Revenue beat(8)2.49%
Revenue beat(12)8
Avg Revenue beat(12)11.44%
Revenue beat(16)12
Avg Revenue beat(16)19.73%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.45%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.65%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.49%
Valuation
Industry RankSector Rank
PE 14.27
Fwd PE 12.64
P/S 3.58
P/FCF 21.82
P/OCF 15.64
P/B 1.96
P/tB 43.75
EV/EBITDA 9.25
EPS(TTM)2.47
EY7.01%
EPS(NY)2.79
Fwd EY7.91%
FCF(TTM)1.62
FCFY4.58%
OCF(TTM)2.25
OCFY6.39%
SpS9.85
BVpS17.98
TBVpS0.81
PEG (NY)0.87
PEG (5Y)0.6
Profitability
Industry RankSector Rank
ROA 8.86%
ROE 10.65%
ROCE 14.43%
ROIC 10.75%
ROICexc 12.47%
ROICexgc 447.49%
OM 30%
PM (TTM) 19.43%
GM 77.45%
FCFM 16.39%
ROA(3y)5.44%
ROA(5y)3.13%
ROE(3y)7.14%
ROE(5y)4.1%
ROIC(3y)6.53%
ROIC(5y)4.35%
ROICexc(3y)7.43%
ROICexc(5y)4.92%
ROICexgc(3y)420.6%
ROICexgc(5y)N/A
ROCE(3y)8.77%
ROCE(5y)5.83%
ROICexcg growth 3Y241.08%
ROICexcg growth 5YN/A
ROICexc growth 3Y204.19%
ROICexc growth 5Y21.2%
OM growth 3Y173.66%
OM growth 5Y12.1%
PM growth 3YN/A
PM growth 5Y11.06%
GM growth 3Y3.85%
GM growth 5Y2.66%
F-Score8
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 123.53%
Cap/Sales 6.48%
Interest Coverage 26.26
Cash Conversion 64.87%
Profit Quality 84.33%
Current Ratio 3.27
Quick Ratio 3.27
Altman-Z 7.2
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)163.76%
Cap/Depr(5y)129.64%
Cap/Sales(3y)8.88%
Cap/Sales(5y)7.75%
Profit Quality(3y)175.31%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.89%
EPS 3Y31.37%
EPS 5Y23.75%
EPS Q2Q%20%
EPS Next Y16.44%
EPS Next 2Y10.33%
EPS Next 3Y6.26%
EPS Next 5Y7.93%
Revenue 1Y (TTM)8.67%
Revenue growth 3Y17.92%
Revenue growth 5Y14.27%
Sales Q2Q%4.11%
Revenue Next Year-6.11%
Revenue Next 2Y-1.18%
Revenue Next 3Y0.72%
Revenue Next 5Y4.07%
EBIT growth 1Y46.53%
EBIT growth 3Y222.7%
EBIT growth 5Y28.1%
EBIT Next Year24.57%
EBIT Next 3Y10.53%
EBIT Next 5Y10.69%
FCF growth 1Y26.81%
FCF growth 3Y38.63%
FCF growth 5Y23.51%
OCF growth 1Y28.71%
OCF growth 3Y31.45%
OCF growth 5Y23.14%